Current Urology Reports

, Volume 14, Issue 4, pp 285–290 | Cite as

Circumcision as a Strategy to Minimize HIV Transmission

  • Imani Jackson Rosario
  • Khushabu Kasabwala
  • Hossein Sadeghi-Nejad
Men's Health (J Mulhall, Section Editor)

Abstract

The newest data related to the Human Immunodeficiency Virus (HIV) / Acquired Immune Disease Syndrome (AIDS) epidemic is primarily positive, but many areas of the world, especially Sub-Saharan Africa, remain disproportionately affected. Between 2005 and 2007, three large randomized trials evaluating circumcision for prevention of HIV acquisition in heterosexual African males showed a reduction in the rate of acquisition of HIV by up to 66 % over 24 months. Since the results of these studies were published, global health organizations have ramped up efforts to help target countries to provide male circumcision delivery services in sub-Saharan Africa. Male circumcision (MC) is cost-effective and efficacious, especially when used in combination with other prevention strategies. Available data shows good acceptability amongst target populations. Neonatal circumcision is well tolerated and more cost effective than adult male circumcision and should be included as part of MC initiatives in the future. Behavioral disinhibition and risk compensation are important factors that may mitigate the rate of risk reduction conferred by male circumcision and should be further investigated. As delivery of male circumcision services is expanded, the issues affecting the female sexual partners of the target population must be outlined and addressed. Whether or not the results of the African trials can be extrapolated to warrant expansion of MC programs to other populations is a critical area for further study.

Keywords

HIV/AIDS Circumcision Sexually transmitted infection Sub-Suharan Africa Epidemic 

Abbreviations

MC

Male circumcision

MMC

Medical male circumcision

UNAIDS

Joint United Nations Program on HIV/AIDS

WHO

World Health Organization

CDC

Centers for Disease Control

HIV

Human Immunodeficiency Virus

AIDS

Acquired Immune Disease Syndrome

ART

Antiretroviral Therapy

TasP

Treatment as Prevention

STI

Sexually Transmitted Infection

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Imani Jackson Rosario reported no potential conflicts of interest relevant to this article.

Dr. Khushabu Kasabwala reported no potential conflicts of interest relevant to this article.

Dr. Hossein Sadeghi-Nejad reported no potential conflicts of interest relevant to this article.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    UNAIDS. Political declaration on HIV and AIDS: Intensifying our efforts to eliminate HIV and AIDS. 2011.Google Scholar
  2. 2.
    UNAIDS. Global AIDS response progress reporting 2012: Guidelines—construction of core indicators for monitoring the 2011 political declaration on HIV/AIDS. 2012.Google Scholar
  3. 3.
    •• UNAIDS. UNAIDS report on the global AIDS epidemic—2012. 2012. Annual UNAIDS report on the status of the AIDS epidemic and update on global initiatives to control it.Google Scholar
  4. 4.
    UNAIDS. UNAIDS report on the global AIDS epidemic—2010. 2010.Google Scholar
  5. 5.
    Centers for Disease Control. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. Dependent areas—2010. HIV surveillance supplemental report 2012;17(no. 3, part a). 2012.Google Scholar
  6. 6.
    Centers for Disease Control. Estimated HIV incidence in the United States, 2007–2010. HIV surveillance supplemental report 2012;17(no. 4). 2012.Google Scholar
  7. 7.
    Templeton DJ. Male circumcision to reduce sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5:344–9.PubMedCrossRefGoogle Scholar
  8. 8.
    •• Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2:e298. One of the three landmark trials demonstrating the protective effect of male circumcision against HIV infection in sub-Saharan Africa.Google Scholar
  9. 9.
    •• Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56. One of the three landmark trials demonstrating the protective effect of male circumcision against HIV infection in sub-Saharan Africa.Google Scholar
  10. 10.
    •• Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66. One of the three landmark trials demonstrating the protective effect of male circumcision against HIV infection in sub-Saharan Africa.Google Scholar
  11. 11.
    Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009:CD003362.Google Scholar
  12. 12.
    Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N, et al. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 2011;8:e1001132.PubMedCrossRefGoogle Scholar
  13. 13.
    Circumcision policy statement. Pediatrics. 2012;130:585-586.Google Scholar
  14. 14.
    Mavhu W, Hatzold K, Laver SM, Sherman J, Tengende BR, Mangenah C, et al. Acceptability of early infant male circumcision as an HIV prevention intervention in zimbabwe: a qualitative perspective. PLoS One. 2012;7:e32475.PubMedCrossRefGoogle Scholar
  15. 15.
    Abbott SA, Haberland NA, Mulenga DM, Hewett PC. Female sex workers, male circumcision and HIV: a qualitative study of their understanding, experience, and HIV risk in Zambia. PLoS One. 2013;8:e53809.PubMedCrossRefGoogle Scholar
  16. 16.
    Grund JM, Hennink MM. A qualitative study of sexual behavior change and risk compensation following adult male circumcision in urban Swaziland. AIDS Care. 2012;24:245–51.PubMedGoogle Scholar
  17. 17.
    Sadeghi-Nejad H, Wasserman M, Weidner W, Richardson D, Goldmeier D. Sexually transmitted diseases and sexual function. J Sex Med. 2010;7:389–413.PubMedCrossRefGoogle Scholar
  18. 18.
    Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9:669–77.PubMedCrossRefGoogle Scholar
  19. 19.
    Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet. 2009;374:229–37.PubMedCrossRefGoogle Scholar
  20. 20.
    Andersson N, Cockcroft A. Male circumcision, attitudes to HIV prevention and HIV status: a cross-sectional study in Botswana, Namibia and Swaziland. AIDS Care. 2012;24:301–9.PubMedCrossRefGoogle Scholar
  21. 21.
    •• Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505. Landmark study showing that early antiretroviral therapy prevents transmission of HIV in serodiscordant couples.PubMedCrossRefGoogle Scholar
  22. 22.
    • Barnighausen T, Bloom DE, Humair S. Economics of antiretroviral treatment vs. Circumcision for HIV prevention. Proc Natl Acad Sci U S A. 2012;109:21271–6. Discusses the relative cost-effectiveness of treatment strategies for HIV. Shows that MC combined with ART is the most cost effective option.PubMedCrossRefGoogle Scholar
  23. 23.
    Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, Barnabas RV, et al. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One. 2013;8:e54575.PubMedCrossRefGoogle Scholar
  24. 24.
    Westercamp M, Agot KE, Ndinya-Achola J, Bailey RC. Circumcision preference among women and uncircumcised men prior to scale-up of male circumcision for HIV prevention in Kisumu, Kenya. AIDS Care. 2012;24:157–66.PubMedGoogle Scholar
  25. 25.
    Centers for Disease Control. Estimated lifetime risk for diagnosis of HIV infection among Hispanics/Latinos—37 states and Puerto Rico, 2007. 2010.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Imani Jackson Rosario
    • 1
  • Khushabu Kasabwala
    • 1
  • Hossein Sadeghi-Nejad
    • 1
    • 2
    • 3
  1. 1.Division of Urology, Department of SurgeryUniversity of Medicine and Dentistry of New JerseyNewarkUSA
  2. 2.Veteran Affairs Medical CenterEast OrangeUSA
  3. 3.Department of UrologyHackensack University Medical CenterHackensackUSA

Personalised recommendations